Literature DB >> 22101806

Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms.

Jingjing Quan1, Newell W Johnson, Guangbiao Zhou, Peter G Parsons, Glen M Boyle, Jin Gao.   

Abstract

Bone invasion is a common characteristic of oral squamous cell carcinoma (OSCC), with adverse affects on patient functionality and survival. Recent studies suggest that it is osteoclasts, rather than malignant keratinocytes themselves, which play the major role in facilitating the entry of the tumour into bone, and its progression within bone. Osteoclasts respond to a variety of local signalling pathways, initiated by products of the malignant epithelial cells. In the present review, we firstly introduce the clinical patterns of bone invasion, and then summarise these signalling pathways and their diverse roles in sequential phases of bone invasion. We also review current researches regarding the incidence and mechanisms of distant metastases to bone, and explain briefly the concept of epithelial-mesenchymal transition, which may generate cancer stem cells and initiate the bone invasion. Finally, we discuss more briefly approaches to the diagnosis and management of OSCC patients with bone invasion. With all these studies and some recent discoveries in our own laboratory, an enhanced understanding of bone invasion will be achieved, which should indicate potential molecular targets for future biotherapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22101806     DOI: 10.1007/s10555-011-9335-7

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  35 in total

1.  Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages.

Authors:  Junda Lin; Ketao Wang; Huayang Wang; Qianqian Shao; Yijun Luan; Yan Xu; Xiaobin Song; Wanye Tan; Shaohua Liu; Fengcai Wei; Xun Qu
Journal:  Med Oncol       Date:  2016-12-21       Impact factor: 3.064

2.  CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.

Authors:  Junhee Park; Xianglan Zhang; Sun Kyoung Lee; Na-Young Song; Seung Hwa Son; Ki Rim Kim; Jae Hoon Shim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

3.  CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma.

Authors:  Guang-Tao Yu; Lin-Lin Bu; Yu-Yue Zhao; Liang Mao; Wei-Wei Deng; Tian-Fu Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

4.  Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.

Authors:  Gustavo Davi Rabelo; Claudia Coutinho-Camillo; Luiz Paulo Kowalski; Nathalie Portero-Muzy; Jean-Paul Roux; Pascale Chavassieux; Fabio Abreu Alves
Journal:  Clin Oral Investig       Date:  2017-06-24       Impact factor: 3.573

5.  Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.

Authors:  A Kolk; T Schuster; A Chlebowski; P Lange; K Scheidhauer; M Kesting; O Bissinger; M Schwaiger; J Dinges; J Weitz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-27       Impact factor: 9.236

6.  Expression of MICA in oral squamous carcinoma cells and its effect on NK cells.

Authors:  Shunjin Chen; Mingang Ying; Xiuan Lin; Xiong Zheng; Chang Liu; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

8.  Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.

Authors:  Fei-Ting Hsu; Betty Chang; John Chun-Hao Chen; I-Tsang Chiang; Yu-Chang Liu; Wei-Kang Kwang; Jeng-Jong Hwang
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

9.  Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts.

Authors:  Jingjing Quan; Moustafa Elhousiny; Newell W Johnson; Jin Gao
Journal:  Clin Exp Metastasis       Date:  2013-02-02       Impact factor: 5.150

10.  Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.

Authors:  Jie Zeng; Jingjing Quan; Xuefeng Xia
Journal:  Mol Med Rep       Date:  2015-11-06       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.